SAG
ABBV icon

SageView Advisory Group’s AbbVie ABBV Stock Holding History

SageView Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.1M Sell
16,291
-2,752
-14% -$592K 0.13% 101
2026
Q1 		$4.14M Sell
19,043
-14,585
-43% -$3.24M 0.15% 79
2025
Q4 		$7.68M Sell
33,628
-2,679
-7% -$610K 0.26% 47
2025
Q3 		$8.41M Buy
36,307
+13,883
+62% +$2.83M 0.29% 42
2025
Q2 		$4.23M Buy
22,424
+4,020
+22% +$747K 0.16% 74
2025
Q1 		$3.86M Buy
18,404
+474
+3% +$92.1K 0.16% 69
2024
Q4 		$3.19M Buy
17,930
+5,327
+42% +$979K 0.14% 83
2024
Q3 		$2.49M Sell
12,603
-5,862
-32% -$1.09M 0.13% 98
2024
Q2 		$3.17M Buy
18,465
+3,935
+27% +$652K 0.15% 85
2024
Q1 		$2.65M Sell
14,530
-7,768
-35% -$1.34M 0.13% 90
2023
Q4 		$3.68M Buy
22,298
+9,460
+74% +$1.38M 0.16% 80
2023
Q3 		$1.91M Sell
12,838
-188
-1% -$27.6K 0.11% 116
2023
Q2 		$1.75M Sell
13,026
-242
-2% -$35.5K 0.1% 127
2023
Q1 		$2.11M Buy
13,268
+3,142
+31% +$480K 0.13% 109
2022
Q4 		$1.64M Buy
+10,126
New +$1.55M 0.13% 108

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SageView Advisory Group's ABBV Position: Q2 2026 in Review

SageView Advisory Group reduced its AbbVie (ABBV) stake by 14% in Q2 2026, selling an estimated $592K and leaving 16,291 shares worth $4.1M. The position accounts for 0.13% of the portfolio, ranked #101.

SageView Advisory Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.41M in Q3 2025. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • SageView Advisory Group held 16,291 shares of AbbVie worth $4.1M as of Q2 2026.
  • SageView Advisory Group sold 2,752 AbbVie shares in Q2 2026, an estimated $592K.
  • AbbVie made up 0.13% of SageView Advisory Group's portfolio in Q2 2026, its #101 holding.
  • SageView Advisory Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • SageView Advisory Group's AbbVie position peaked at $8.41M in Q3 2025.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.